In a recent spotlight on cancer therapies, researchers highlight fenbendazole, a widely used veterinary dewormer, for its potential anticancer properties. This interest stems from a combination of new research, animal studies, and human experiences, suggesting that fenbendazole probably has a role in human cancer therapy.
A comprehensive review published in the Anticancer Research Journal discusses fenbendazole’s pharmacokinetics and potential anticancer effects in humans and animals.
The study, which has not been approved by health regulatory bodies influenced by Big Pharma like the FDA or EMA for human cancer therapy, highlights fenbendazole’s low cost, accessibility, and high safety profile.
The research points out that while fenbendazole’s exact mechanism in cancer treatment needs more exploration, its ability to target cancer cells selectively in vitro and animal models is promising. This review calls for clinical trials to assess its efficacy, optimal dosages, and human safety.
Complementing this research, a case study from the Brasilian Journal of Medicina Complementar presents evidence that fenbendazole has been used as a treatment regimen for cancer patients. The study discusses the case of fenbendazole being administered to patients in combination with or without other anticancer drugs, suggesting a possible synergistic effect in some instances.
While these are not controlled scientific studies, they provide a narrative that aligns with the laboratory findings, indicating fenbendazole might warrant further scrutiny in clinical settings if the industry allows.
As usual, some researchers offer a more cautious view that these findings need more validation. On the one hand, there’s growing evidence and preliminary research suggesting fenbendazole could be used in cancer treatment. On the other hand, formal scientific evaluations have not fully confirmed its efficacy or safety for this purpose in humans.
This scenario has sparked a debate in both the scientific community and among those seeking alternative cancer treatments. The conversation around fenbendazole and its potential in cancer treatment remains open. There are calls for more research to bridge the gap between intriguing preliminary results and clinically proven treatments.
Sources and related
- Medicina Complementar: Fenbendazole Enhancing Anti-Tumor Effect: A Case Series
- Anti-Cancer Research: Oral Fenbendazole for Cancer Therapy in Humans and Animals
- Anti-Cancer Research: Fenbendazole as a Potential Anticancer Drug
- Anti-Cancer Research: Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells